AYURVEDIC ALTERNATIVES IN AUTOIMMUNITY
AYURVEDIC ALTERNATIVES IN AUTOIMMUNITY
批准号:
7809453
负责人:
CHANDRA MOHAN
金额:
$19.43万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2011-04-30
关键词:
Adverse effectsAffectAllelesAlternative MedicineAnemiaAtypical lymphocyteAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityAyurvedic MedicineAzathioprineB-LymphocytesBreedingCardiovascular systemCell physiologyCellsCessation of lifeChromosomes, Human, Pair 1Chromosomes, Human, Pair 4Chromosomes, Human, Pair 7Chronic DiseaseComplexCongenic StrainCurcuminCyclophosphamideDendritic CellsDevelopmentDiseaseDistalDoseEndocrineExhibitsFractureFutureGeneticGenetic ModelsGoalsHumanHyperactive behaviorImmune ToleranceImmune systemImmunosuppressive AgentsIndividualInflammationInflammatoryKidneyLupusLupus NephritisLymphocyteMapsMedication ManagementModalityModelingMolecularMorbidity - disease rateMouse StrainsMusMycosesNephritisNeurologicNuclearOrganPathogenesisPatientsPharmaceutical PreparationsPhenotypePopulationPredispositionProto-Oncogene Proteins c-aktResearchRiskSLEB1 geneSLEB2 geneSLEB3 geneSignal TransductionStagingSteroidsSusceptibility GeneSystemic Lupus ErythematosusT-Cell ActivationTestingTherapeuticThrombocytopeniaTissuesViralWorkbasecongenicefficacy testingexperienceinterestlupus prone micemortalitymouse modelmycophenolate mofetilnovelpreventpublic health relevancereconstitutionsystemic autoimmune diseasetreatment strategy
中文摘要
描述(由申请人提供):治疗全身性自身免疫性疾病的常规药物通常与长期副作用有关。这促进了对这些疾病的替代或补充治疗方式的研究,包括系统性红斑狼疮。基于姜黄素对其他几种慢性疾病的疗效,阿育吠陀补充剂,姜黄素在狼疮治疗中有很大的希望-然而,这从未被直接测试。我们最近在小鼠模型中的工作发现了狼疮发展中至少三个主要的检查点--淋巴细胞对自身抗原的耐受性被打破,过度活跃的促炎树突状细胞放大了自身免疫过程,以及终末器官炎症,尤其影响到肾脏。最近已经产生了遗传简化的小鼠模型,包括这些单独的检查点。这项应用的目标是使用这些新的遗传模型来了解姜黄素是否以及如何影响免疫耐受、树突状细胞功能和/或终末器官炎症。剖析替代治疗方案在自身免疫中的作用机制将使我们最终能够根据患者的基因构成来优化狼疮的补充治疗策略。
公共卫生相关性:治疗系统性红斑狼疮的常规药物往往与长期副作用有关。在这种情况下,“天然补充剂”如果被证明是有效的,可能特别有用。基于它对其他几种慢性疾病的疗效,阿育吠陀补充剂,姜黄素在狼疮治疗中有很大的希望。拟议的研究将确定姜黄素可能在狼疮中发挥作用的确切检查点和作用机制。这项研究的发现可能会对我们未来如何使用天然补充剂治疗人类SLE产生深远的影响。
英文摘要
DESCRIPTION (provided by applicant): Conventional medications for the management of systemic autoimmune diseases are often associated with long-term side-effects. This has spurred research into alternative or complementary treatment modalities for these diseases, including systemic lupus erythematosus. Based on its efficacy in several other chronic diseases, the Ayurvedic supplement, curcumin holds great promise in lupus treatment - however, this has never been tested directly. Our recent work in mouse models has uncovered at least 3 major checkpoints in lupus development - breach in lymphocyte tolerance to self antigens, amplification of the autoimmune process by hyperactive, pro-inflammatory dendritic cells, and end-organ inflammation, affecting the kidneys in particular. Genetically simplified mouse models have recently been generated, encompassing these individual checkpoints. The goal of this application is to use these novel genetic models to understand if and how curcumin might impact immune tolerance, dendritic cell function and/or end-organ inflammation. Dissecting out the mechanism of action of alternative therapeutic regimes in autoimmunity will allow us to eventually optimize complementary treatment strategies for lupus, tailored to the genetic makeup of the patient.
PUBLIC HEALTH RELEVANCE: Conventional medications for the management of SLE are often associated with long- term side-effects. In this context, "natural supplements" may be particularly useful if proven effective. Based on its efficacy in several other chronic diseases, the Ayurvedic supplement, curcumin holds great promise in lupus treatment. The proposed studies will ascertain the precise check-points and mechanisms of action through which curcumin might work in lupus. The findings from this study could have a profound impact on how we use natural supplements in treating human SLE in the future.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0119543
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Ye T, Zhen J, Du Y, Zhou JK, Peng A, Vaziri ND, Mohan C, Xu Y, Zhou XJ]
通讯作者:
Zhou XJ
Diagnostic utility of antibodies to post-translationally modified nucleosomes in lupus nephritis
-
批准号:10683684
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2023
-
负责人:CHANDRA MOHAN
-
依托单位:
Objective Classification of Lupus Nephritis
-
批准号:10683624
-
项目类别:
-
资助金额:$66.94万
-
财政年份:2023
-
负责人:CHANDRA MOHAN
-
依托单位:
Lupus Nephritis Neural Network, LuNN
-
批准号:10246669
-
项目类别:
-
资助金额:$10.08万
-
财政年份:2020
-
负责人:CHANDRA MOHAN
-
依托单位:
Monitoring Disease in Lupus
-
批准号:10583454
-
项目类别:
-
资助金额:$54.2万
-
财政年份:2019
-
负责人:CHANDRA MOHAN
-
依托单位:
Monitoring Disease in Lupus
-
批准号:9889903
-
项目类别:
-
资助金额:$54.2万
-
财政年份:2019
-
负责人:CHANDRA MOHAN
-
依托单位:
Monitoring Disease in Lupus
-
批准号:10352313
-
项目类别:
-
资助金额:$53.66万
-
财政年份:2019
-
负责人:CHANDRA MOHAN
-
依托单位:
A B-Cell Gene for Lupus
-
批准号:10403586
-
项目类别:
-
资助金额:$40.06万
-
财政年份:2018
-
负责人:CHANDRA MOHAN
-
依托单位:
Novel Point of Care assays for Urinary Diagnostics of Nephritis
-
批准号:9570651
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2017
-
负责人:CHANDRA MOHAN
-
依托单位:
Novel Point of Care assays for Urinary Diagnostics of Nephritis
-
批准号:9753123
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2017
-
负责人:CHANDRA MOHAN
-
依托单位:
Candidate Genes for BXSB Lupus
-
批准号:8274814
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2011
-
负责人:CHANDRA MOHAN
-
依托单位:
Foreboding Lupus Nephritis in Minority Woman
-
批准号:8329662
-
项目类别:
-
资助金额:$44.24万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
LUPUS GENES AND B-CELL SIGNALING
-
批准号:8050071
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
Genetic Dissection of B-Cell Signaling Pathways in Lupus
-
批准号:7941908
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
AYURVEDIC ALTERNATIVES IN AUTOIMMUNITY
-
批准号:7660250
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
Foreboding Lupus Nephritis in Minority Woman
-
批准号:7728622
-
项目类别:
-
资助金额:$53.23万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
LUPUS GENES AND B-CELL SIGNALING
-
批准号:8449031
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
Foreboding Lupus Nephritis in Minority Woman
-
批准号:8132541
-
项目类别:
-
资助金额:$44.68万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
Foreboding Lupus Nephritis in Minority Woman
-
批准号:7916604
-
项目类别:
-
资助金额:$51.29万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
LUPUS GENES AND B-CELL SIGNALING
-
批准号:8242648
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
LUPUS GENES AND B-CELL SIGNALING
-
批准号:7653974
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2009
-
负责人:CHANDRA MOHAN
-
依托单位:
海外基金